Search details
1.
Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase.
Hepatology
; 78(5): 1558-1568, 2023 11 01.
Article
in English
| MEDLINE | ID: mdl-37184202
2.
Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis B.
Dig Dis
; 41(1): 115-123, 2023.
Article
in English
| MEDLINE | ID: mdl-36070707
3.
Natural History and Hepatocellular Carcinoma Risk in Untreated Chronic Hepatitis B Patients With Indeterminate Phase.
Clin Gastroenterol Hepatol
; 20(8): 1803-1812.e5, 2022 08.
Article
in English
| MEDLINE | ID: mdl-33465482
4.
Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational Cohort.
Clin Gastroenterol Hepatol
; 20(10): 2393-2395.e4, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-33486083
5.
Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice.
Hepatology
; 74(2): 656-666, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33706421
6.
Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV.
Dig Dis Sci
; 67(6): 2637-2645, 2022 06.
Article
in English
| MEDLINE | ID: mdl-34059991
7.
Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis B.
J Infect Dis
; 223(1): 139-146, 2021 01 04.
Article
in English
| MEDLINE | ID: mdl-32525978
8.
Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B.
J Infect Dis
; 224(2): 294-302, 2021 07 15.
Article
in English
| MEDLINE | ID: mdl-33249474
9.
Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid Diseases.
Clin Gastroenterol Hepatol
; 19(5): 996-1008.e6, 2021 05.
Article
in English
| MEDLINE | ID: mdl-32629123
10.
Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir.
Am J Gastroenterol
; 116(6): 1264-1273, 2021 06 01.
Article
in English
| MEDLINE | ID: mdl-34074829
11.
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy.
J Infect Dis
; 221(3): 389-399, 2020 01 14.
Article
in English
| MEDLINE | ID: mdl-31550363
12.
Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis.
Gastroenterology
; 156(3): 635-646.e9, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30342034
13.
Poor Adherence to Guidelines for Treatment of Chronic Hepatitis B Virus Infection at Primary Care and Referral Practices.
Clin Gastroenterol Hepatol
; 17(5): 957-967.e7, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30326298
14.
Serum Aminotransferase Flares in Pregnant and Postpartum Women With Current or Prior Treatment for Chronic Hepatitis B.
J Clin Gastroenterol
; 52(3): 255-261, 2018 03.
Article
in English
| MEDLINE | ID: mdl-28323748
15.
HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.
Am J Gastroenterol
; 112(7): 1111-1119, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28440303
16.
Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B.
J Hepatol
; 65(3): 509-16, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27210427
17.
Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B.
Am J Gastroenterol
; 111(10): 1410-1415, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27456990
18.
Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice.
J Clin Gastroenterol
; 50(2): 169-74, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26018133
19.
Alternative Therapies for Chronic Hepatitis B Patients With Partial Virological Response to Standard Entecavir Monotherapy.
J Clin Gastroenterol
; 50(4): 338-44, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-26646801
20.
Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation.
Dig Dis Sci
; 61(2): 618-25, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26660679